Fangying Yu

782 total citations
32 papers, 625 citations indexed

About

Fangying Yu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Fangying Yu has authored 32 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 11 papers in Molecular Biology and 9 papers in Biomaterials. Recurrent topics in Fangying Yu's work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (9 papers) and Lipid Membrane Structure and Behavior (4 papers). Fangying Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (9 papers) and Lipid Membrane Structure and Behavior (4 papers). Fangying Yu collaborates with scholars based in China, Czechia and Hong Kong. Fangying Yu's co-authors include Fuqiang Hu, Hong Yuan, Cheng Wang, Yun Zhu, Shaoqing Chen, Xuerong Liu, Tingting Meng, Yupeng Liu, Shan Tao and Yanan Tan and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Fangying Yu

32 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangying Yu China 14 365 254 198 123 92 32 625
Jian-Bin Qiao China 14 268 0.7× 267 1.1× 299 1.5× 122 1.0× 62 0.7× 20 811
Jiangkang Xu China 11 320 0.9× 198 0.8× 245 1.2× 85 0.7× 79 0.9× 12 623
Alexey V. Yaremenko Russia 14 370 1.0× 284 1.1× 260 1.3× 149 1.2× 65 0.7× 25 789
Zhaoqing Cong China 13 355 1.0× 239 0.9× 227 1.1× 79 0.6× 46 0.5× 26 681
Xiyou Du China 14 274 0.8× 197 0.8× 190 1.0× 92 0.7× 126 1.4× 27 596
Beom Suk Lee South Korea 14 246 0.7× 272 1.1× 273 1.4× 76 0.6× 49 0.5× 21 651
Jingyi An China 12 352 1.0× 147 0.6× 254 1.3× 135 1.1× 52 0.6× 21 637
Haijing Qu China 15 430 1.2× 315 1.2× 258 1.3× 119 1.0× 79 0.9× 30 700
Zhaoming Guo China 19 443 1.2× 310 1.2× 306 1.5× 229 1.9× 86 0.9× 39 858

Countries citing papers authored by Fangying Yu

Since Specialization
Citations

This map shows the geographic impact of Fangying Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangying Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangying Yu more than expected).

Fields of papers citing papers by Fangying Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangying Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangying Yu. The network helps show where Fangying Yu may publish in the future.

Co-authorship network of co-authors of Fangying Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangying Yu. A scholar is included among the top collaborators of Fangying Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangying Yu. Fangying Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Jianping, et al.. (2025). Recent advances in nanomaterials and their mechanisms for infected wounds management. Materials Today Bio. 31. 101553–101553. 12 indexed citations
3.
Wang, Zixu, Fangying Yu, & Fuqiang Hu. (2024). Functional Chitosan and Its Derivative-Related Drug Delivery Systems for Nano-Therapy: Recent Advances. Pharmaceutics. 16(3). 337–337. 10 indexed citations
4.
Zhou, Wentao, Yupeng Liu, Tingting Meng, et al.. (2024). NIR-Triggered Thermosensitive Nanoreactors for Dual-Guard Mechanism-Mediated Precise and Controllable Cancer Chemo-Phototherapy. Biomacromolecules. 25(2). 964–974. 4 indexed citations
5.
Wang, Zixu, Shanshan Xiang, Fangying Yu, et al.. (2024). An “Iron-phagy” nanoparticle inducing irreversible mitochondrial damages for antitumor therapy. Journal of Controlled Release. 374. 400–414. 1 indexed citations
6.
Wang, Zixu, et al.. (2024). Chitosan-derived drug free “artificial beacon” simulating immunogenetic cell death cascade effector to initiate immune response for cancer therapy. International Journal of Biological Macromolecules. 287. 138434–138434. 1 indexed citations
7.
Yu, Fangying, Zixu Wang, Yun Zhu, et al.. (2023). Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis. Materials Today Bio. 18. 100532–100532. 21 indexed citations
8.
Peng, Lijun, Fangying Yu, Tingting Meng, et al.. (2023). Glutathione Consumptive Dual-Sensitive Lipid-Composite Nanoparticles Induce Immunogenic Cell Death for Enhanced Breast Tumor Therapy. Molecular Pharmaceutics. 21(1). 113–125. 1 indexed citations
9.
Hu, Jieying, et al.. (2022). Microenvironment Regulation of Metal–Organic Frameworks to Anchor Transition Metal Ions for the Electrocatalytic Hydrogen Evolution Reaction. Inorganic Chemistry. 61(48). 19475–19482. 8 indexed citations
10.
Liu, Yupeng, Fangying Yu, Suhuan Dai, et al.. (2021). All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis. Molecular Pharmaceutics. 18(11). 3966–3978. 28 indexed citations
11.
Yu, Fangying, Yun Zhu, Yupeng Liu, et al.. (2021). Self-preparation system using glucose oxidase-inspired nitroreductase amplification for cascade-responsive drug release and multidrug resistance reversion. Biomaterials. 275. 120927–120927. 32 indexed citations
13.
Tao, Shan, Shaoqing Chen, Wentao Zhou, et al.. (2020). A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively. RSC Advances. 10(35). 20445–20459. 22 indexed citations
14.
Chen, Shaoqing, Cheng Wang, Yanqing Song, et al.. (2020). Quercetin Covalently Linked Lipid Nanoparticles: Multifaceted Killing Effect on Tumor Cells. ACS Omega. 5(46). 30274–30281. 9 indexed citations
15.
Tao, Shan, Fangying Yu, Yanqing Song, et al.. (2020). Water/pH dual responsive in situ calcium supplement collaborates simvastatin for osteoblast promotion mediated osteoporosis therapy via oral medication. Journal of Controlled Release. 329. 121–135. 29 indexed citations
16.
Zhu, Yun, Fangying Yu, Yanan Tan, et al.. (2020). <p>Guiding Appropriate Timing of Laser Irradiation by Polymeric Micelles for Maximizing Chemo-Photodynamic Therapy</p>. International Journal of Nanomedicine. Volume 15. 6531–6543. 11 indexed citations
17.
Chen, Shaoqing, Yanqing Song, Cheng Wang, et al.. (2019). Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Carbohydrate Polymers. 230. 115613–115613. 62 indexed citations
18.
Wang, Cheng, Fangying Yu, Xuerong Liu, et al.. (2019). Cancer‐Specific Therapy by Artificial Modulation of Intracellular Calcium Concentration. Advanced Healthcare Materials. 8(18). e1900501–e1900501. 48 indexed citations
19.
Zhu, Yun, Tingting Meng, Yanan Tan, et al.. (2018). Negative Surface Shielded Polymeric Micelles with Colloidal Stability for Intracellular Endosomal/Lysosomal Escape. Molecular Pharmaceutics. 15(11). 5374–5386. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026